Walleye Capital’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,258
| Closed | -$837 | – | 2572 |
|
|
2024
Q3 | $837 | Hold |
23,258
| – | – | ﹤0.01% | 2401 |
|
|
2024
Q2 | $1.1K | Hold |
23,258
| – | – | ﹤0.01% | 2576 |
|
|
2024
Q1 | $907 | Hold |
23,258
| – | – | ﹤0.01% | 2574 |
|
|
2023
Q4 | $702 | Hold |
23,258
| – | – | ﹤0.01% | 2076 |
|
|
2023
Q3 | $1.63K | Hold |
23,258
| – | – | ﹤0.01% | 2137 |
|
|
2023
Q2 | $2.43K | Hold |
23,258
| – | – | ﹤0.01% | 1926 |
|
|
2023
Q1 | $837 | Hold |
23,258
| – | – | ﹤0.01% | 2030 |
|
|
2022
Q4 | $1.09K | Hold |
23,258
| – | – | ﹤0.01% | 2013 |
|
|
2022
Q3 | $1K | Hold |
23,258
| – | – | ﹤0.01% | 2176 |
|
|
2022
Q2 | $3K | Hold |
23,258
| – | – | ﹤0.01% | 2150 |
|
|
2022
Q1 | $11K | Hold |
23,258
| – | – | ﹤0.01% | 2009 |
|
|
2021
Q4 | $42K | Sell |
23,258
-25,135
| -52% | -$45.4K | ﹤0.01% | 1741 |
|
|
2021
Q3 | $45 | Buy |
48,393
+3,393
| +8% | +$3 | ﹤0.01% | 1372 |
|
|
2021
Q2 | $41 | Buy |
+45,000
| New | +$41 | ﹤0.01% | 1222 |
|